[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Johnson & Johnson](/topic/johnson-johnson)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:johnson-johnson/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/johnson-johnson/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% +7%  
**1 Month**: XX% +1%  
**6 Months**: XX% +11%  
**1 Year**: XX% +20%  
**1-Year High**: XX% on 2025-06-04  
**1-Year Low**: XX% on 2024-12-14  

**Most Supportive Themes**
- **Positive Outlook on JNJ's Pharma Business:** (25%) Analysts are optimistic about Johnson & Johnson's (JNJ) pharmaceutical business, citing strong drug sales and potential for growth.
- **JNJ's Dividend and Financial Stability:** (15%) Several posts highlight JNJ's consistent dividend payouts and financial stability, making it an attractive investment for income-focused investors.
- **Positive Developments in Ulcerative Colitis Treatment:** (10%) Positive data from Icotrokinra and Tremfya in ulcerative colitis trials are being highlighted, suggesting potential for a standout combination of therapeutic benefit and a favorable safety profile.
  
**Most Critical Themes**
- **Talc Lawsuit and Legal Challenges:** (30%)  A recent jury verdict ordered Johnson & Johnson to pay a significant amount in a talc-related cancer case, raising concerns about ongoing litigation and potential financial impacts.
- **Concerns about Tylenol and Autism:** (20%)  Reports and internal records suggest that Johnson & Johnson may have been aware of potential links between Tylenol and autism, leading to criticism and scrutiny.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %   | Negative | %   |
| ------- | -------- | -  | ------- | -   | -------- | -   |
| X       | XXXXXX   | X% | XXXXXX  | X%  | XXXXX    | X%  |
| Reddit  | XXX      | X% | XXX     | X%  | X        | X%  |
| TikTok  | XXXXX    | X% | XXXXXX  | X%  | XXXXXXX  | XX% |
| YouTube | XXXXX    | X% | XXXXXX  | X%  | XXXXXXX  | XX% |
| News    | X        | X% | XXX     | X%  | XXX      | X%  |
|         |          |    |         |     |          |     |
| Total   | XXXXXX   | X% | XXXXXX  | XX% | XXXXXXX  | XX% |